A comprehensive meta-analysis of 12 new-generation antidepressants has shown sertraline and escitalopram have clear advantages in terms of efficacy and acceptability, while reboxetine was shown to be the significantly less efficacious than the other 11 drugs. The

Early results of a randomized controlled clinical trial suggest that the SSRI drug escitalopram (brand names Lexapro, Cipralex) may benefit older
adults with generalized anxiety disorder, although it is likely the trial failed to show clear overall benefits compared with placebo because some trial
patients dropped out. The researchers said the drug needs to be tested […]

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.
Study results showed that patients new to antidepressant treatment

Two studies presented today at the 8th International Forum on Mood and Anxiety Disorders (IFMAD) in Vienna demonstrated that once-daily SEROQUEL XRTM (quetiapine fumarate extended release tablets) provided significant symptom relief for elderly patients (>65 years of age) with major depressive disorder (MDD)